07.30.25
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
07.30.25
Tryptyr Now Available in US07.16.25
AECOS Presentation SummariesShow More